Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Cancer cell lines predict drug response, study shows

    Author:
    HT Staff
    Publish date: July 8, 2016

    Image from PNAS A study published in Cell has shown that patient-derived cancer cell lines harbor most of the same genetic changes found in...

    • Read More

    News

    Mutations may be a ‘missing link’ in AML

    Author:
    HT Staff
    Publish date: July 8, 2016

    Research published in Nature Communications suggests that mutations in the ZBTB7A gene are associated with t(8;21)-rearranged acute myeloid...

    • Read More

    News

    Material can dissolve blood clots more efficiently, team says

    Author:
    HT Staff
    Publish date: July 8, 2016

    Image by Kevin MacKenzie Researchers say they have developed a thrombolytic material that can be condensed on a blood clot by means of a magnetic...

    • Read More

    News

    NICE recommends approval for bosutinib

    Author:
    HT Staff
    Publish date: July 8, 2016

    Photo courtesy of CDC The National Institute for Health and Care Excellence (NICE) has issued a final draft guidance recommending approval for...

    • Read More

    News

    NHL patients may have higher risk of second cancer

    Author:
    HT Staff
    Publish date: July 7, 2016

    Photo courtesy of NIH Compared to patients with other common cancers, patients with non-Hodgkin lymphoma (NHL) have a higher risk of developing a...

    • Read More

    News

    Results support INR self-monitoring/management

    Author:
    HT Staff
    Publish date: July 7, 2016

    Results of a systematic review support self-monitoring and self-management for patients on long-term oral anticoagulation therapy. Researchers...

    • Read More

    News

    Study reveals global variations of P vivax

    Author:
    HT Staff
    Publish date: July 7, 2016

    from patients in Thailand Image by Wanlapa Roobsoong Researchers say they have uncovered the global, evolving, and historic make-up of the...

    • Read More

    News

    EC extends marketing authorization for brentuximab vedotin

    Author:
    HT Staff
    Publish date: July 7, 2016

    Photo from Business Wire The European Commission (EC) has extended the current conditional marketing authorization of brentuximab vedotin (...

    • Read More

    News

    Drugs produce comparable results in CP-CML

    Author:
    HT Staff
    Publish date: July 6, 2016

    Long-term results from the DASISION trial suggest that dasatinib and imatinib produce similar outcomes in patients with newly diagnosed chronic...

    • Read More

    News

    EC expands approved use of carfilzomib

    Author:
    HT Staff
    Publish date: July 6, 2016

    Photo from Amgen The European Commission (EC) has expanded the approved use of the proteasome inhibitor carfilzomib (Kyprolis). The drug is now...

    • Read More

    News

    How multiple infections make malaria worse

    Author:
    HT Staff
    Publish date: July 6, 2016

    Image by Ute Frevert and Margaret Shear New research suggests that infections with 2 types of malaria parasite lead to greater health risks...

    • Read More

    News

    Study explains link between malignant hyperthermia and bleeding abnormalities

    Author:
    HT Staff
    Publish date: July 6, 2016

    A new study helps explain why some patients with malignant hyperthermia may suffer from excessive bleeding. The findings suggest a mutation that...

    • Read More

    News

    Team identifies potential therapeutic target for AML

    Author:
    HT Staff
    Publish date: July 5, 2016

    New research suggests that E proteins and their antagonists, Id proteins, can play key roles in acute myeloid leukemia (AML). The study showed...

    • Read More

    News

    Study reveals SNPs that may increase risk of MM

    Author:
    HT Staff
    Publish date: July 4, 2016

    A large study has revealed several genetic variations that may increase a person’s risk of developing multiple myeloma (MM). The findings,...

    • Read More

    News

    Efficacy of malaria vaccine declines over time

    Author:
    HT Staff
    Publish date: July 3, 2016

    Photo by Caitlin Kleiboer Results from a phase 2 study of the malaria vaccine RTS,S (also known as RTS,S/AS01 or Mosquirix) suggest its efficacy...

    • Read More

    Pages

    • « first
    • …
    • 109
    • 110
    • 111
    • 112
    • 113
    • 114
    • 115
    • 116
    • 117
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery